Weekly News Wire | May 3, 2021

Massachusetts General Hospital Partners Will Pilot AstraZeneca Digital Care Management App For Asthma & Heart Failure

On April 6, 2021 AstraZeneca, a global, science-led biopharmaceutical company, announced it is collaborating with Massachusetts General Hospital (MGH) to pilot a digital chronic care management platform to improve care management of asthma and heart failure. This collaboration is being led by the MGH Center for Innovation in Digital HealthCare (CIDH) who will use AstraZeneca’s new AMAZE™ disease management platform in studies for heart failure and asthma management.

AMAZE is intended to act as a personalized communication tool between the consumer and their health care professionals. The AMAZE app lets consumers access protected health information through a secure . . .

Want To Read More? Log In Or Become A Paid Member

Resource Available For Paid OPEN MINDS Circle Members Only

Not a paid member? Don't miss out! Sign up today and receive unlimited organizational access to all OPEN MINDS strategic advice, market intelligence, and management best practices – over 250,000 resources!

If you are already a paid member, log in to your account to access this resource and more. If you are a free member, you will need to upgrade to a paid membership before accessing this resource.

Become A Paid Member

If you are not yet a paid member, learn more about the OPEN MINDS Circle Market Intelligence Service Membership on our website, reach out to our team at info@openminds.com, or call us at 877-350-6463.

About

Contact

Partnership

Massachusetts General Hospital Partners Will Pilot AstraZeneca Digital Care Management App For Asthma & Heart Failure

Tagged As:

About

Contact

Partnership

Markets

Services

Customers

Publications

Markets

Topics

Executive Institutes

Professional Development Programs

Tools

Assessments

Tagged As: